APA (7th ed.) Citation

Wick, W., & Bendszus, M. (2016). Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma. Neuro-Oncology, 18(10), . https://doi.org/10.1093/neuonc/now091

Chicago Style (17th ed.) Citation

Wick, Wolfgang, and Martin Bendszus. "Evaluation of Pseudoprogression Rates and Tumor Progression Patterns in a Phase III Trial of Bevacizumab Plus Radiotherapy/temozolomide for Newly Diagnosed Glioblastoma." Neuro-Oncology 18, no. 10 (2016). https://doi.org/10.1093/neuonc/now091.

MLA (9th ed.) Citation

Wick, Wolfgang, and Martin Bendszus. "Evaluation of Pseudoprogression Rates and Tumor Progression Patterns in a Phase III Trial of Bevacizumab Plus Radiotherapy/temozolomide for Newly Diagnosed Glioblastoma." Neuro-Oncology, vol. 18, no. 10, 2016, https://doi.org/10.1093/neuonc/now091.